publication venue for
- Increased inflammasome protein expression identified in microglia from postmortem brains with schizophrenia. 2024
- ZCCHC17 knockdown phenocopies Alzheimer's disease-related loss of synaptic proteins and hyperexcitability.. 83:626-635. 2024
- Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease.. 83:2-10. 2023
- LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry.. 82:760-768. 2023
- The status of digital pathology and associated infrastructure within Alzheimer's Disease Centers.. 82:202-211. 2023
- Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status.. 82:110-119. 2023
- Postmortem 7T MRI for guided histopathology and evaluation of cerebrovascular disease.. 82:57-70. 2022
- Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.. 81:781-789. 2022
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.. 80:102-111. 2021
- Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology.. 79:1379-1381. 2020
- Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy.. 79:465-473. 2020
- Speech and Language Presentations of FTLD-TDP Type B Neuropathology.. 79:277-283. 2020
- FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.. 78:844-853. 2019
- A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders.. 78:406-415. 2019
- Combined Pathologies in FTLD-TDP Types A and C.. 77:405-412. 2018
- Argyrophilic Grain Disease: Demographics, Clinical, and Neuropathological Features From a Large Autopsy Study.. 75:628-35. 2016
- Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.. 75:516-26. 2016
- Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition.. 75:955-962. 2016
- Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.. 69:667-76. 2010
- Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.. 68:994-1005. 2009
- Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions.. 68:785-96. 2009
- Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.. 68:515-24. 2009
- Targeting prion amyloid deposits in vivo.. 63:775-84. 2004
- Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.. 63:418-28. 2004
- Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy.. 60:274-9. 2001
- Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease.. 57:674-83. 1998